The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
1 Report Overview 1.1 Study Scope and Definition 1.2 Research Methodology 1.2.1 Methodology/Research Approach 1.2.2 Data Source 1.3 Key Market Segments 1.4 Players Covered: Ranking by Nuclear Medicine/Radiopharmaceutic Revenue 1.5 Market Analysis by Type 1.5.1 Global Nuclear Medicine/Radiopharmaceutic Market Size Growth Rate by Type: 2020 VS 2026 1.5.2 Tc-99 1.5.3 I-123/131 1.5.4 In-111 1.5.5 Xe-133 1.5.6 Th-201 1.5.7 Ga-67 1.5.8 Other 1.6 Market by Application 1.6.1 Global Nuclear Medicine/Radiopharmaceutic Market Share by Application: 2021-2026 1.6.2 Diagnostic 1.6.3 Therapeutic 1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth 1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections 1.7.2 Covid-19 Impact: Commodity Prices Indices 1.7.3 Covid-19 Impact: Global Major Government Policy 1.8 Study Objectives 1.9 Years Considered 2 Global Nuclear Medicine/Radiopharmaceutic Market Trends and Growth Strategy 2.1 Market Top Trends 2.2 Market Drivers 2.3 Market Challenges 2.4 Porter's Five Forces Analysis 2.5 Market Growth Strategy 2.6 SWOT Analysis 3 Global Nuclear Medicine/Radiopharmaceutic Market Players Profiles 3.1 GE Healthcare 3.1.1 GE Healthcare Company Profile 3.1.2 GE Healthcare Nuclear Medicine/Radiopharmaceutic Product Specification 3.1.3 GE Healthcare Nuclear Medicine/Radiopharmaceutic Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.2 Eli Lilly 3.2.1 Eli Lilly Company Profile 3.2.2 Eli Lilly Nuclear Medicine/Radiopharmaceutic Product Specification 3.2.3 Eli Lilly Nuclear Medicine/Radiopharmaceutic Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.3 Lantheus Medical Imaging 3.3.1 Lantheus Medical Imaging Company Profile 3.3.2 Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Product Specification 3.3.3 Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.4 Bracco Imaging 3.4.1 Bracco Imaging Company Profile 3.4.2 Bracco Imaging Nuclear Medicine/Radiopharmaceutic Product Specification 3.4.3 Bracco Imaging Nuclear Medicine/Radiopharmaceutic Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.5 Nordion 3.5.1 Nordion Company Profile 3.5.2 Nordion Nuclear Medicine/Radiopharmaceutic Product Specification 3.5.3 Nordion Nuclear Medicine/Radiopharmaceutic Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.6 Mallinckrodt 3.6.1 Mallinckrodt Company Profile 3.6.2 Mallinckrodt Nuclear Medicine/Radiopharmaceutic Product Specification 3.6.3 Mallinckrodt Nuclear Medicine/Radiopharmaceutic Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.7 China Isotope & Radiation 3.7.1 China Isotope & Radiation Company Profile 3.7.2 China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Product Specification 3.7.3 China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.8 Jubilant Pharma 3.8.1 Jubilant Pharma Company Profile 3.8.2 Jubilant Pharma Nuclear Medicine/Radiopharmaceutic Product Specification 3.8.3 Jubilant Pharma Nuclear Medicine/Radiopharmaceutic Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.9 Bayer 3.9.1 Bayer Company Profile 3.9.2 Bayer Nuclear Medicine/Radiopharmaceutic Product Specification 3.9.3 Bayer Nuclear Medicine/Radiopharmaceutic Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.10 SIEMENS 3.10.1 SIEMENS Company Profile 3.10.2 SIEMENS Nuclear Medicine/Radiopharmaceutic Product Specification 3.10.3 SIEMENS Nuclear Medicine/Radiopharmaceutic Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.11 Yantai Dongcheng Biochemicals 3.11.1 Yantai Dongcheng Biochemicals Company Profile 3.11.2 Yantai Dongcheng Biochemicals Nuclear Medicine/Radiopharmaceutic Product Specification 3.11.3 Yantai Dongcheng Biochemicals Nuclear Medicine/Radiopharmaceutic Production Capacity, Revenue, Price and Gross Margin (2015-2020) 4 Global Nuclear Medicine/Radiopharmaceutic Market Competition by Market Players 4.1 Global Nuclear Medicine/Radiopharmaceutic Production Capacity Market Share by Market Players (2015-2020) 4.2 Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Market Players (2015-2020) 4.3 Global Nuclear Medicine/Radiopharmaceutic Average Price by Market Players (2015-2020) 5 Global Nuclear Medicine/Radiopharmaceutic Production by Regions (2015-2020) 5.1 North America 5.1.1 North America Nuclear Medicine/Radiopharmaceutic Market Size (2015-2020) 5.1.2 Nuclear Medicine/Radiopharmaceutic Key Players in North America (2015-2020) 5.1.3 North America Nuclear Medicine/Radiopharmaceutic Market Size by Type (2015-2020) 5.1.4 North America Nuclear Medicine/Radiopharmaceutic Market Size by Application (2015-2020) 5.2 East Asia 5.2.1 East Asia Nuclear Medicine/Radiopharmaceutic Market Size (2015-2020) 5.2.2 Nuclear Medicine/Radiopharmaceutic Key Players in East Asia (2015-2020) 5.2.3 East Asia Nuclear Medicine/Radiopharmaceutic Market Size by Type (2015-2020) 5.2.4 East Asia Nuclear Medicine/Radiopharmaceutic Market Size by Application (2015-2020) 5.3 Europe 5.3.1 Europe Nuclear Medicine/Radiopharmaceutic Market Size (2015-2020) 5.3.2 Nuclear Medicine/Radiopharmaceutic Key Players in Europe (2015-2020) 5.3.3 Europe Nuclear Medicine/Radiopharmaceutic Market Size by Type (2015-2020) 5.3.4 Europe Nuclear Medicine/Radiopharmaceutic Market Size by Application (2015-2020) 5.4 South Asia 5.4.1 South Asia Nuclear Medicine/Radiopharmaceutic Market Size (2015-2020) 5.4.2 Nuclear Medicine/Radiopharmaceutic Key Players in South Asia (2015-2020) 5.4.3 South Asia Nuclear Medicine/Radiopharmaceutic Market Size by Type (2015-2020) 5.4.4 South Asia Nuclear Medicine/Radiopharmaceutic Market Size by Application (2015-2020) 5.5 Southeast Asia 5.5.1 Southeast Asia Nuclear Medicine/Radiopharmaceutic Market Size (2015-2020) 5.5.2 Nuclear Medicine/Radiopharmaceutic Key Players in Southeast Asia (2015-2020) 5.5.3 Southeast Asia Nuclear Medicine/Radiopharmaceutic Market Size by Type (2015-2020) 5.5.4 Southeast Asia Nuclear Medicine/Radiopharmaceutic Market Size by Application (2015-2020) 5.6 Middle East 5.6.1 Middle East Nuclear Medicine/Radiopharmaceutic Market Size (2015-2020) 5.6.2 Nuclear Medicine/Radiopharmaceutic Key Players in Middle East (2015-2020) 5.6.3 Middle East Nuclear Medicine/Radiopharmaceutic Market Size by Type (2015-2020) 5.6.4 Middle East Nuclear Medicine/Radiopharmaceutic Market Size by Application (2015-2020) 5.7 Africa 5.7.1 Africa Nuclear Medicine/Radiopharmaceutic Market Size (2015-2020) 5.7.2 Nuclear Medicine/Radiopharmaceutic Key Players in Africa (2015-2020) 5.7.3 Africa Nuclear Medicine/Radiopharmaceutic Market Size by Type (2015-2020) 5.7.4 Africa Nuclear Medicine/Radiopharmaceutic Market Size by Application (2015-2020) 5.8 Oceania 5.8.1 Oceania Nuclear Medicine/Radiopharmaceutic Market Size (2015-2020) 5.8.2 Nuclear Medicine/Radiopharmaceutic Key Players in Oceania (2015-2020) 5.8.3 Oceania Nuclear Medicine/Radiopharmaceutic Market Size by Type (2015-2020) 5.8.4 Oceania Nuclear Medicine/Radiopharmaceutic Market Size by Application (2015-2020) 5.9 South America 5.9.1 South America Nuclear Medicine/Radiopharmaceutic Market Size (2015-2020) 5.9.2 Nuclear Medicine/Radiopharmaceutic Key Players in South America (2015-2020) 5.9.3 South America Nuclear Medicine/Radiopharmaceutic Market Size by Type (2015-2020) 5.9.4 South America Nuclear Medicine/Radiopharmaceutic Market Size by Application (2015-2020) 5.10 Rest of the World 5.10.1 Rest of the World Nuclear Medicine/Radiopharmaceutic Market Size (2015-2020) 5.10.2 Nuclear Medicine/Radiopharmaceutic Key Players in Rest of the World (2015-2020) 5.10.3 Rest of the World Nuclear Medicine/Radiopharmaceutic Market Size by Type (2015-2020) 5.10.4 Rest of the World Nuclear Medicine/Radiopharmaceutic Market Size by Application (2015-2020) 6 Global Nuclear Medicine/Radiopharmaceutic Consumption by Region (2015-2020) 6.1 North America 6.1.1 North America Nuclear Medicine/Radiopharmaceutic Consumption by Countries 6.1.2 United States 6.1.3 Canada 6.1.4 Mexico 6.2 East Asia 6.2.1 East Asia Nuclear Medicine/Radiopharmaceutic Consumption by Countries 6.2.2 China 6.2.3 Japan 6.2.4 South Korea 6.3 Europe 6.3.1 Europe Nuclear Medicine/Radiopharmaceutic Consumption by Countries 6.3.2 Germany 6.3.3 United Kingdom 6.3.4 France 6.3.5 Italy 6.3.6 Russia 6.3.7 Spain 6.3.8 Netherlands 6.3.9 Switzerland 6.3.10 Poland 6.4 South Asia 6.4.1 South Asia Nuclear Medicine/Radiopharmaceutic Consumption by Countries 6.4.2 India 6.5 Southeast Asia 6.5.1 Southeast Asia Nuclear Medicine/Radiopharmaceutic Consumption by Countries 6.5.2 Indonesia 6.5.3 Thailand 6.5.4 Singapore 6.5.5 Malaysia 6.5.6 Philippines 6.6 Middle East 6.6.1 Middle East Nuclear Medicine/Radiopharmaceutic Consumption by Countries 6.6.2 Turkey 6.6.3 Saudi Arabia 6.6.4 Iran 6.6.5 United Arab Emirates 6.7 Africa 6.7.1 Africa Nuclear Medicine/Radiopharmaceutic Consumption by Countries 6.7.2 Nigeria 6.7.3 South Africa 6.8 Oceania 6.8.1 Oceania Nuclear Medicine/Radiopharmaceutic Consumption by Countries 6.8.2 Australia 6.9 South America 6.9.1 South America Nuclear Medicine/Radiopharmaceutic Consumption by Countries 6.9.2 Brazil 6.9.3 Argentina 6.10 Rest of the World 6.10.1 Rest of the World Nuclear Medicine/Radiopharmaceutic Consumption by Countries 7 Global Nuclear Medicine/Radiopharmaceutic Production Forecast by Regions (2021-2026) 7.1 Global Forecasted Production of Nuclear Medicine/Radiopharmaceutic (2021-2026) 7.2 Global Forecasted Revenue of Nuclear Medicine/Radiopharmaceutic (2021-2026) 7.3 Global Forecasted Price of Nuclear Medicine/Radiopharmaceutic (2021-2026) 7.4 Global Forecasted Production of Nuclear Medicine/Radiopharmaceutic by Region (2021-2026) 7.4.1 North America Nuclear Medicine/Radiopharmaceutic Production, Revenue Forecast (2021-2026) 7.4.2 East Asia Nuclear Medicine/Radiopharmaceutic Production, Revenue Forecast (2021-2026) 7.4.3 Europe Nuclear Medicine/Radiopharmaceutic Production, Revenue Forecast (2021-2026) 7.4.4 South Asia Nuclear Medicine/Radiopharmaceutic Production, Revenue Forecast (2021-2026) 7.4.5 Southeast Asia Nuclear Medicine/Radiopharmaceutic Production, Revenue Forecast (2021-2026) 7.4.6 Middle East Nuclear Medicine/Radiopharmaceutic Production, Revenue Forecast (2021-2026) 7.4.7 Africa Nuclear Medicine/Radiopharmaceutic Production, Revenue Forecast (2021-2026) 7.4.8 Oceania Nuclear Medicine/Radiopharmaceutic Production, Revenue Forecast (2021-2026) 7.4.9 South America Nuclear Medicine/Radiopharmaceutic Production, Revenue Forecast (2021-2026) 7.4.10 Rest of the World Nuclear Medicine/Radiopharmaceutic Production, Revenue Forecast (2021-2026) 7.5 Forecast by Type and by Application (2021-2026) 7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026) 7.5.2 Global Forecasted Consumption of Nuclear Medicine/Radiopharmaceutic by Application (2021-2026) 8 Global Nuclear Medicine/Radiopharmaceutic Consumption Forecast by Regions (2021-2026) 8.1 North America Forecasted Consumption of Nuclear Medicine/Radiopharmaceutic by Country 8.2 East Asia Market Forecasted Consumption of Nuclear Medicine/Radiopharmaceutic by Country 8.3 Europe Market Forecasted Consumption of Nuclear Medicine/Radiopharmaceutic by Countriy 8.4 South Asia Forecasted Consumption of Nuclear Medicine/Radiopharmaceutic by Country 8.5 Southeast Asia Forecasted Consumption of Nuclear Medicine/Radiopharmaceutic by Country 8.6 Middle East Forecasted Consumption of Nuclear Medicine/Radiopharmaceutic by Country 8.7 Africa Forecasted Consumption of Nuclear Medicine/Radiopharmaceutic by Country 8.8 Oceania Forecasted Consumption of Nuclear Medicine/Radiopharmaceutic by Country 8.9 South America Forecasted Consumption of Nuclear Medicine/Radiopharmaceutic by Country 8.10 Rest of the world Forecasted Consumption of Nuclear Medicine/Radiopharmaceutic by Country 9 Global Nuclear Medicine/Radiopharmaceutic Sales by Type (2015-2026) 9.1 Global Nuclear Medicine/Radiopharmaceutic Historic Market Size by Type (2015-2020) 9.2 Global Nuclear Medicine/Radiopharmaceutic Forecasted Market Size by Type (2021-2026) 10 Global Nuclear Medicine/Radiopharmaceutic Consumption by Application (2015-2026) 10.1 Global Nuclear Medicine/Radiopharmaceutic Historic Market Size by Application (2015-2020) 10.2 Global Nuclear Medicine/Radiopharmaceutic Forecasted Market Size by Application (2021-2026) 11 Global Nuclear Medicine/Radiopharmaceutic Manufacturing Cost Analysis 11.1 Nuclear Medicine/Radiopharmaceutic Key Raw Materials Analysis 11.1.1 Key Raw Materials 11.2 Proportion of Manufacturing Cost Structure 11.3 Manufacturing Process Analysis of Nuclear Medicine/Radiopharmaceutic 12 Global Nuclear Medicine/Radiopharmaceutic Marketing Channel, Distributors, Customers and Supply Chain 12.1 Marketing Channel 12.2 Nuclear Medicine/Radiopharmaceutic Distributors List 12.3 Nuclear Medicine/Radiopharmaceutic Customers 12.4 Nuclear Medicine/Radiopharmaceutic Supply Chain Analysis 13 Analyst's Viewpoints/Conclusions 14 Disclaimer
Price : US$ 3,500 | Date : Apr 2024 |
Category : Manufacturing and Construction | Pages : 116 |
Price : US$ 3,500 | Date : Mar 2024 |
Category : Energy, Mining and Utilities | Pages : 233 |
Price : US$ 3,500 | Date : Feb 2024 |
Category : Healthcare and Pharmaceuticals | Pages : 145 |
Price : US$ 3,500 | Date : Feb 2024 |
Category : Energy, Mining and Utilities | Pages : 100 |
Price : US$ 3,500 | Date : Jan 2024 |
Category : Healthcare and Pharmaceuticals | Pages : 110 |
We will be happy to help you find what you need. Please call us or write to us: